These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency. Bosson D; Kuhnle U; Mees N; Ramet J; Vamos E; Vertongen F; Wolter R; Armanini D Acta Endocrinol Suppl (Copenh); 1986; 279():376-80. PubMed ID: 2946135 [TBL] [Abstract][Full Text] [Related]
45. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity. Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457 [TBL] [Abstract][Full Text] [Related]
49. Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids. Wehling M; Eisen C; Christ M Mol Cell Endocrinol; 1992 Dec; 90(1):C5-9. PubMed ID: 1338726 [TBL] [Abstract][Full Text] [Related]
50. Renin-aldosterone system evaluation over four decades in an extended family with autosomal dominant pseudohypoaldosteronism due to a deletion in the NR3C2 gene. Hanukoglu A; Vargas-Poussou R; Landau Z; Yosovich K; Hureaux M; Zennaro MC J Steroid Biochem Mol Biol; 2020 Nov; 204():105755. PubMed ID: 33017655 [TBL] [Abstract][Full Text] [Related]
51. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene. Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms of type I and type II pseudohypoaldosteronism. Furgeson SB; Linas S J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405 [TBL] [Abstract][Full Text] [Related]
54. Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism. Arai K; Nakagomi Y; Iketani M; Shimura Y; Amemiya S; Ohyama K; Shibasaki T Hum Genet; 2003 Jan; 112(1):91-7. PubMed ID: 12483305 [TBL] [Abstract][Full Text] [Related]
55. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810 [TBL] [Abstract][Full Text] [Related]
56. Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1. Hubert EL; Teissier R; Fernandes-Rosa FL; Fay M; Rafestin-Oblin ME; Jeunemaitre X; Metz C; Escoubet B; Zennaro MC J Am Soc Nephrol; 2011 Nov; 22(11):1997-2003. PubMed ID: 21903996 [TBL] [Abstract][Full Text] [Related]
57. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism. Sartorato P; Lapeyraque AL; Armanini D; Kuhnle U; Khaldi Y; Salomon R; Abadie V; Di Battista E; Naselli A; Racine A; Bosio M; Caprio M; Poulet-Young V; Chabrolle JP; Niaudet P; De Gennes C; Lecornec MH; Poisson E; Fusco AM; Loli P; Lombès M; Zennaro MC J Clin Endocrinol Metab; 2003 Jun; 88(6):2508-17. PubMed ID: 12788847 [TBL] [Abstract][Full Text] [Related]
58. Reducing αENaC expression in the kidney connecting tubule induces pseudohypoaldosteronism type 1 symptoms during K+ loading. Poulsen SB; Praetorius J; Damkier HH; Miller L; Nelson RD; Hummler E; Christensen BM Am J Physiol Renal Physiol; 2016 Feb; 310(4):F300-10. PubMed ID: 26582762 [TBL] [Abstract][Full Text] [Related]
59. A novel frameshift mutation in NR3C2 leads to decreased expression of mineralocorticoid receptor: a family with renal pseudohypoaldosteronism type 1. Kawashima Sonoyama Y; Tajima T; Fujimoto M; Hasegawa A; Miyahara N; Nishimura R; Hashida Y; Hayashi A; Hanaki K; Kanzaki S Endocr J; 2017 Jan; 64(1):83-90. PubMed ID: 27725360 [TBL] [Abstract][Full Text] [Related]
60. Pseudohypoaldosteronism: evaluation of type I receptors by radioreceptor assay and by antireceptor antibodies. Armanini D; Karbowiak I; Zennaro CM; Zovato S; Pratesi C; De Lazzari P; Krozowski Z; Kuhnle U Steroids; 1995 Jan; 60(1):161-3. PubMed ID: 7792805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]